“Development of CXCR4-Targeting Antagonists for Acute Myocardial Infarction Therapy” has been awarded the 18th National Innovation Award in the Academic Research Category by the Research Center for Biotechnology and Medicine Policy.
“Development of CXCR4-Targeting Antagonists for Acute Myocardial Infarction Therapy” has been awarded the 18th National Innovation Award in the Academic Research Category by the Research Center for Biotechnology and Medicine Policy.